These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4274769)

  • 1. Letter: Abortion for Down's syndrome.
    Bergin JD
    N Z Med J; 1974 Feb; 79(509):711. PubMed ID: 4274769
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of induced abortion on the incidence of Down's syndrome in Hawaii.
    Smith RG; Gardner RW; Steinhoff P; Chung CS; Palmore JA
    Fam Plann Perspect; 1980; 12(4):201-5. PubMed ID: 6449372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary prevention of Down's syndrome in Czechoslovakia 1975-1980].
    Kucera J
    Cesk Pediatr; 1982 Jul; 37(7):404-8. PubMed ID: 6215132
    [No Abstract]   [Full Text] [Related]  

  • 5. The ethics of using modern technology for detecting Down's syndrome.
    Churchman J
    Radiogr Today; 1989 Jul; 55(626):25. PubMed ID: 2531595
    [No Abstract]   [Full Text] [Related]  

  • 6. Down's syndrome, amniocentesis, and abortion: prevention or elimination?
    Smith JD
    Ment Retard; 1981 Feb; 19(1):8-11. PubMed ID: 6454053
    [No Abstract]   [Full Text] [Related]  

  • 7. The prospects for "preventing" Down's syndrome in an English region.
    Forster DP
    Rev Epidemiol Sante Publique; 1980 Dec; 28(4):423-30. PubMed ID: 6452660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics, amniocentesis, and abortion.
    Hirschhorn K
    Mt Sinai J Med; 1984; 51(1):15-7. PubMed ID: 6608672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fetal diagnosis and medical ethics].
    Shimada N
    Josanpu Zasshi; 1981 Aug; 35(8):640. PubMed ID: 6915120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Down syndrome and abortion].
    Rev Paul Med; 1985; 103(5):267-8. PubMed ID: 2938248
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prognosis work-up in prenatal medicine: the example of Down's syndrome].
    Winaver D
    Gynecol Obstet Fertil; 2005 Dec; 33(12):1058. PubMed ID: 16316771
    [No Abstract]   [Full Text] [Related]  

  • 14. Twin pregnancy, abortion of one fetus with Down's syndrome by sectio parva, the other delivered mature and healthy.
    Beck L; Terinde R; Röhrborn G; Claussen U; Gebauer HJ; Rehder H
    Eur J Obstet Gynecol Reprod Biol; 1981 Nov; 12(5):267-9. PubMed ID: 6460653
    [No Abstract]   [Full Text] [Related]  

  • 15. [Screening for Down's syndrome in the 2d trimester of pregnancy: initial results].
    Stejskal D
    Cesk Gynekol; 1993 Feb; 58(1):5-10. PubMed ID: 8319282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similarities in women's decision-making in the U.S. and U.K. during prenatal screening for Down's syndrome.
    Haddow JE; Palomaki GE
    Prenat Diagn; 1996 Dec; 16(12):1161-2. PubMed ID: 8994255
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prognosis work-up in prenatal medicine: the example of Down's syndrome].
    Shojai R; Boubli L; d'Ercole C
    Gynecol Obstet Fertil; 2005; 33(7-8):514-9. PubMed ID: 16005658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening.
    Leporrier N; Herrou M; Morello R; Leymarie P
    BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.